NCT00394056View on ClinicalTrials.gov

Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.

PHASE2CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Tinnitus

Interventions

DRUG

Vestipitant

NK1 receptor antagonist

DRUG

Vestipitant + Paroxetine

NK1 receptor antagonist and SSRI

OTHER

Placebo

Placebo

Trial Locations (1)

CB2 2GG

GSK Investigational Site, Cambridge

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY